Clinical Trials Logo
  1. Home
  2. Hyperparathyroidism
  3. NCT03968510
  4. Details
NCT03968510 Clinical Trial

Swalqol in Primary Hyperparathyroidism

Hyperparathyroidism Clinical Trial

Official title:
The Effect of Parathyroidectomy on Swallowing Related Quality of Life in Primary Hyperparathyroidism

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03968510
Other study ID # pthswalqol
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2018
Est. completion date November 1, 2020

Study information
Verified date June 2021
Source Usak University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Swallow related quality of life before and after parathyroidectomy will be evaluated in patients with primary hyperparathyridism.

Description:

Patients who will undergone parathyroidectomy for primary hyperparathyroidism will be included in the study. Swal-Qol and Sf-36 forms will be used for evaluation of quality of life before and 1 month after the surgery. The change in the quality of life and swallowing related quality of life will be evaluated.

Recruitment information / eligibility
Status Completed
Enrollment 150
Est. completion date November 1, 2020
Est. primary completion date July 1, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - no diagnosis of Alzheimers disease - must be able to swallow tablets Planned operation for primary hyperparathyroidism Exclusion Criteria: - secondary or tertiary hyperparathyroidism - insulin dependent diabetes - thyroid disease

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• parathyroidectomy
routine parathyroidectomy will be done for the treatment of adenoma

Locations
Country Name City State
Turkey Usak University Usak

Sponsors (1)
Lead Sponsor Collaborator
Usak University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change in quality of life Quality of life will be evaluated using short form 36 6 months
See also
  Status Clinical Trial Phase
Completed NCT00377312 - 7 Day Continuous Parathyroid Hormone IV Infusion Phase 0
Completed NCT00379899 - ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis Phase 4
Completed NCT04040946 - Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention Phase 3
Recruiting NCT03053999 - Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
Withdrawn NCT02711059 - Insulin Resistance in Primary Hyperparathyroidism N/A
Completed NCT01691781 - The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study N/A
Completed NCT00538720 - Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT) Phase 1
Completed NCT00887666 - Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure N/A
Terminated NCT03044600 - Gene Expression in Hyperparathyroidism
Completed NCT03747029 - Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre Study
Completed NCT01872429 - Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients N/A
Completed NCT00800358 - Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism N/A
Recruiting NCT00169806 - Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis N/A
Completed NCT00501215 - Effect of Parathyroidectomy on Sleep N/A
Completed NCT02591160 - Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism N/A
Recruiting NCT05299632 - F-18 PSMA for Localization of Parathyroid Adenoma
Recruiting NCT02986607 - Corticosteroid Rhythms in Hypoparathyroid Patients Early Phase 1
Completed NCT02432599 - Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas Phase 2
Completed NCT02524041 - Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism N/A
Recruiting NCT05667090 - Effects of Multiple Mega-dose of Vitamin D3 Supplementation on Ameliorating Moderate to Severe Chronic Pain in Hemodialysis Patients N/A